Abstract
Purpose. Deoxoartemisinin is a semisynthetic antimalarial with potential for treatment of multiple drug resistant malaria. Metabolism studies were conducted to aid in future drug development.
Methods. Microbial model systems were employed which have been shown to be good predictors of mammalian drug metabolites. Metabolism studies using rats were also performed.
Results. Three microbial metabolites of deoxoartemisinin were identified (2, 3, and 4). Metabolite 3 was also found in rat plasma. HPLC/MS analyses were performed on the rat plasma using 2, 3, and 4 as standards. All metabolites were thoroughly characterized by 1H and 13C-NMR. An additional rat plasma metabolite was revealed and it was shown not to be 9α-hydroxyartemisinin.
Conclusions. Deoxoartemisinin was metabolized to three microbial metabolites. Metabolism by rats showed the presence of two metabolites in the plasma, one of which was the same as the microbial metabolite.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
D.L. Klayman. Qinghaosu (artemisinin): An antimalarial drug from China. Science, 228, 1049–1055 (1985).
T. T. Hien and N. J. White. Qinghaosu. Lancet, 341, 603–608 (1993).
M. Jung, X. Li, D.A. Bustos, H.N. ElSohly, J.D. McChesney, W. K. Milhous. Synthesis and Antimalarial Activity of (+)-Deoxoartemisinin. J. Med. Chem., 33, 1516–1518 (1990).
A.M. Clark, J.D. McChesney, and C.D. Hufford. The Use of Microorganisms for the Study of Drug Metabolism. Med. Res. Rev., 5, 231–253 (1985).
A.M. Clark and C.D. Hufford. Use of Microorganisms for the Study of Drug Metabolism: An Update. Med. Res. Rev., 11, 473–501 (1991).
F.S. ElFeraly and C.D. Hufford. Synthesis and Carbon-13 Nuclear Magnetic Resonance Assignments of Xenognosin. J. Org. Chem., 47, 1527–1530 (1982).
S.A. Elmarakby, A.M. Clark, J.K. Baker, and C.D. Hufford. Microbial Metabolism of Bornaprine, 3-(Diethylamino)propyl 2-Phenylbicyclo[2.2.1]heptane-2-carboxylate. J. Pharm. Sci., 75, 614–618 (1986).
C.D. Fortner, W.R. Grove, D. Bowie, and M.D. Walker. Fat emulsion vehicle for intravenous administration of an aqueous insoluble drug. Am. J. Hosp. Pharm., 22, 582–584 (1975).
C.D. Hufford, I.-S. Lee, H.N. ElSohly, H.T. Chi, and J.K. Baker. Structure Elucidation and Thermospray High-Performance Liquid Chromatography/Mass Spectroscopy (HPLC/MS) of the Microbial and Mammalian Metabolites of the Antimalarial Arteether. Pharm. Res., 7, 923–927 (1990).
I.-S. Lee, H.N. ElSohly, and C.D. Hufford. Microbial Metabolism Studies of the Antimalarial Drug Arteether. Pharm. Res, 7, 199–203 (1990).
A.J. Lin, D.L. Klayman, J.M. Hoch, J.V. Silverton, and C.F. George. Thermal Rearrangement and Decomposition Products of Artemisinin (Quinghaosu). J. Org. Chem., 50, 4504–4508 (1985).
I.-S. Lee, and C.D. Hufford. Metabolism of antimalarial sesquiterpene lactones. Pharmac. Ther., 48, 345–355 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khalifa, S.I., Baker, J.K., Jung, M. et al. Microbial and Mammalian Metabolism Studies on the Semisynthetic Antimalarial, Deoxoartemisinin. Pharm Res 12, 1493–1498 (1995). https://doi.org/10.1023/A:1016239505506
Issue Date:
DOI: https://doi.org/10.1023/A:1016239505506